Saturday, July 11, 2026

pharma · Polycythemia Vera (PV) · Primary Myelofibrosis

PharmaEssentia

PharmaEssentia trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Burlington, USA HQ
2003 Founded
356 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Burlington, USA
Founded
2003
Employees
356
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Trials

PharmaEssentia clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to PharmaEssentia programs — each row shows trial ID, program name, phase, status, and indication.

PharmaEssentia trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for PharmaEssentia.

  1. Ropeginterferon alfa-2b — Phase 3

    Clinical update
  2. P1101 — Phase 3

    Clinical update

Trial registry

2 studies